![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, December 05, 2022 10:10:24 PM
The similarity between the two drugs is they are both trying to slip under the COVID therapeutic wire, and they are both tiny, foreign entity penny stocks. Unfortunately the FDA is tends to favor USA based pharmaceuticals, and/or Big Pharm in general. So RVVTF does have a shot at it. I'm just not optimistic based on the FDA track record. Nor am I bearish though.
What you are omitting is the Relief drug (aviptadil) was essentially stolen and received full EUA in India. It's being used there with patients now. Also, the NIH / FDA trial was with the IV version of the drug, not inhaled. You are missing a ton of DD. Not that it matters.
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM